Zensar Technolgies Ltd.
ZENSARTECHInformation Technology filings
We hold this company’s filings and have not read the financial statements out of them yet. Every filing on record is listed under filings, and each one opens.
Earnings calls
18 transcript(s)/analyst meet(s) served; 9 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 18 documents here); elsewhere sentences render unattributed.
| Kind | Date | Period | Served | Attribution rate |
|---|---|---|---|---|
| TRANSCRIPT | 20190129 | 2018-12-31 | yes | |
| COVER_LETTER | 20220517 | 2022-03-31 | no | |
| COVER_LETTER | 20220812 | 2022-06-30 | no | |
| COVER_LETTER | 20221028 | 2022-09-30 | no | |
| TRANSCRIPT | 20230131 | 2022-12-31 | yes | |
| TRANSCRIPT | 20230517 | 2023-03-31 | yes | |
| TRANSCRIPT | 20230726 | 2023-06-30 | yes | |
| TRANSCRIPT | 20240130 | 2023-12-31 | yes | |
| TRANSCRIPT | 20240502 | 2024-03-31 | yes | |
| TRANSCRIPT | 20240729 | 2024-06-30 | yes | |
| COVER_LETTER | 20241029 | 2024-09-30 | no | |
| COVER_LETTER | 20250129 | 2024-12-31 | no | |
| COVER_LETTER | 20250502 | 2025-03-31 | no | |
| TRANSCRIPT | 20250728 | 2025-06-30 | yes | |
| TRANSCRIPT | 20251110 | 2025-09-30 | yes | |
| COVER_LETTER | 20260201 | 2025-12-31 | no | |
| COVER_LETTER | 20260504 | 2026-03-31 | no | |
| COVER_LETTER | 20260805 | 2026-06-30 | no |
ZENSARTECH
files the standard Schedule III statements. Every figure below opens to the filing it was read from; where a figure is not shown, the reason is printed in its place.
Identity
| Statement division | general |
| Scope served | consolidated |
| Panels on this page | 4 |
Market
No split, bonus or consolidation is on record for this company inside the period this price series covers, so the closes need no adjustment.
| Last close | 422.55 |
| 52-week range | 422.55 – 808.0 |
| Return 1M | -10.5% |
| Return 3M | -5.13% |
| Return 1Y | -47.7% |
| Return 3Y | -20.32% |
| Return 5Y | -17.03% |
| Market capitalisation | not shown — we could not confirm it |
| Shares outstanding | not shown — we could not confirm it |
| P/E | not shown — we could not confirm it |
| P/B | not shown — we could not confirm it |
| EV/EBITDA | not shown — we could not confirm it |
Latest quarter filed — period ending 2026-06-30
In INR crore except per-share figures. `period_id` is the period the filing names for the number; the date beside each cell is when it was filed.
| Revenue from operations | 1,508.00 |
| Other income | 57.00 |
| Total income | 1,566.00 |
| Cost of materials consumed | 0.00 |
| Purchases of stock-in-trade | 11.00 |
| Changes in inventories | 0.00 |
| Employee benefit expense | 922.00 |
| Finance costs | 4.00 |
Ownership — 2026-06-30, and the change from 2026-03-31
| Holder | Per cent | Change |
|---|---|---|
| promoter and promoter group | 0.49 | -0.00 |
| institutions foreign | 0.11 | 0.00 |
| institutions domestic | 0.22 | -0.02 |
| mutual funds | 0.20 | -0.01 |
| public | 0.51 | 0.00 |
Documents on file
| Class | Most recent | On file |
|---|---|---|
| COVER_LETTER | 2026-06-30 | 9 |
| TRANSCRIPT | 2025-09-30 | 9 |
Financial statements
Filed results, consolidated, in INR crore except per-share figures. Every figure opens to the filing it was read from. Quarterly and annual columns are the periods the filing itself names, never a document date.
Quarterly results, as filed
| Line | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 1,235.00 | 1,198.00 | 1,213.00 | 1,227.00 | 1,241.00 | 1,204.00 | 1,230.00 | 1,288.00 | 1,308.00 | 1,326.00 | 1,359.00 | 1,385.00 | 1,421.00 | 1,431.00 | 1,450.00 | 1,508.00 |
| Other income | 28.00 | 26.00 | 27.00 | 28.00 | 36.00 | 42.00 | 52.00 | 42.00 | 41.00 | 31.00 | 46.00 | 57.00 | 49.00 | 63.00 | 65.00 | 57.00 |
| Total income | 1,263.00 | 1,224.00 | 1,240.00 | 1,256.00 | 1,277.00 | 1,246.00 | 1,282.00 | 1,330.00 | 1,349.00 | 1,356.00 | 1,405.00 | 1,442.00 | 1,470.00 | 1,494.00 | 1,515.00 | 1,566.00 |
| Cost of materials consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of stock-in-trade | 49.00 | 30.00 | 6.00 | 1.00 | 3.00 | 2.00 | 1.00 | 4.00 | 17.00 | 17.00 | 15.00 | 8.00 | 12.00 | 8.00 | 11.00 | 11.00 |
| Changes in inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employee benefit expense | 809.00 | 775.00 | 799.00 | 766.00 | 780.00 | 777.00 | 780.00 | 816.00 | 843.00 | 846.00 | 885.00 | 876.00 | 925.00 | 895.00 | 935.00 | 922.00 |
| Finance costs | 8.00 | 8.00 | 6.00 | 6.00 | 6.00 | 6.00 | 3.00 | 4.00 | 4.00 | 4.00 | 5.00 | 4.00 | 4.00 | 2.00 | 2.00 | 4.00 |
| Depreciation and amortisation | 49.00 | 50.00 | 35.00 | 42.00 | 37.00 | 31.00 | 24.00 | 25.00 | 30.00 | 24.00 | 24.00 | 23.00 | 25.00 | 20.00 | 23.00 | 28.00 |
| Other expenses | 271.00 | 258.00 | 232.00 | 230.00 | 227.00 | 218.00 | 246.00 | 272.00 | 247.00 | 256.00 | 246.00 | 290.00 | 264.00 | 278.00 | 269.00 | 354.00 |
| Total expenses | 1,186.00 | 1,120.00 | 1,078.00 | 1,045.00 | 1,052.00 | 1,034.00 | 1,053.00 | 1,121.00 | 1,141.00 | 1,146.00 | 1,175.00 | 1,201.00 | 1,230.00 | 1,203.00 | 1,240.00 | 1,319.00 |
| Profit before exceptional items and tax | 77.00 | 104.00 | 162.00 | 210.00 | 225.00 | 212.00 | 229.00 | 210.00 | 208.00 | 210.00 | 230.00 | 241.00 | 240.00 | 290.00 | 275.00 | 246.00 |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -25.00 | 0.00 | 0.00 |
| Profit before tax | 77.00 | 104.00 | 162.00 | 210.00 | 225.00 | 212.00 | 229.00 | 210.00 | 208.00 | 210.00 | 230.00 | 241.00 | 240.00 | 265.00 | 276.00 | 246.00 |
| Current tax | 16.00 | 29.00 | 79.00 | 70.00 | 54.00 | 58.00 | 44.00 | 55.00 | 58.00 | 50.00 | 40.00 | 56.00 | 55.00 | 59.00 | 53.00 | 65.00 |
| Deferred tax | 4.00 | -2.00 | -37.00 | -16.00 | -3.00 | -8.00 | 11.00 | -3.00 | -6.00 | 1.00 | 13.00 | 2.00 | 3.00 | 6.00 | 12.00 | -3.00 |
| Tax expense | 20.00 | 27.00 | 42.00 | 54.00 | 51.00 | 50.00 | 55.00 | 52.00 | 52.00 | 50.00 | 53.00 | 59.00 | 58.00 | 65.00 | 65.00 | 62.00 |
| Profit for the period | 57.00 | 76.00 | 119.00 | 156.00 | 174.00 | 162.00 | 173.00 | 158.00 | 156.00 | 160.00 | 176.00 | 182.00 | 182.00 | 200.00 | 211.00 | 184.00 |
| Profit attributable to owners | 57.00 | 76.00 | 119.00 | 156.00 | 174.00 | 162.00 | 173.00 | 158.00 | 156.00 | — | 176.00 | 182.00 | — | 200.00 | 211.00 | 184.00 |
| Profit attributable to non-controlling interests | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
| Other comprehensive income | -5.00 | 30.00 | 17.00 | 15.00 | -3.00 | -2.00 | 11.00 | -3.00 | -16.00 | 33.00 | 17.00 | 25.00 | 33.00 | 24.00 | 59.00 | 2.00 |
| Total comprehensive income | 52.00 | 106.00 | 136.00 | 172.00 | 171.00 | 160.00 | 184.00 | 154.00 | 139.00 | 193.00 | 193.00 | 207.00 | 216.00 | 224.00 | 269.00 | 186.00 |
| Earnings per share, basic | 2.51 | 3.38 | 5.27 | 6.90 | 7.68 | 7.14 | 7.65 | 6.96 | 6.88 | 7.04 | 7.77 | 8.01 | 8.02 | 8.80 | 9.29 | 8.11 |
| Earnings per share, diluted | 2.48 | 3.36 | 5.24 | 6.84 | 7.61 | 7.08 | 7.59 | 6.91 | 6.82 | 6.98 | 7.68 | 7.92 | 7.93 | 8.67 | 9.15 | 7.99 |
Annual results, as filed
| Line | 2019-03-31 | 2020-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|---|---|---|
| Revenue from operations | 3,966.00 | 4,182.00 | 4,244.00 | 4,848.00 | 4,902.00 | 5,281.00 | 5,687.00 |
| Other income | 93.00 | 88.00 | 138.00 | 103.00 | 159.00 | 160.00 | 234.00 |
| Total income | 4,059.00 | 4,270.00 | 4,382.00 | 4,951.00 | 5,061.00 | 5,441.00 | 5,921.00 |
| Cost of materials consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of stock-in-trade | 115.00 | 152.00 | 110.00 | 132.00 | 7.00 | 53.00 | 39.00 |
| Changes in inventories | 73.00 | 31.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employee benefit expense | 2,786.00 | 3,006.00 | 2,575.00 | 3,123.00 | 3,102.00 | 3,390.00 | 3,631.00 |
| Finance costs | 37.00 | 61.00 | 35.00 | 28.00 | 21.00 | 17.00 | 12.00 |
| Depreciation and amortisation | 89.00 | 159.00 | 185.00 | 183.00 | 134.00 | 102.00 | 91.00 |
| Other expenses | 513.00 | 485.00 | 902.00 | 1,041.00 | 921.00 | 1,020.00 | 1,101.00 |
| Total expenses | 3,614.00 | 3,894.00 | 3,807.00 | 4,507.00 | 4,185.00 | 4,583.00 | 4,875.00 |
| Profit before exceptional items and tax | 445.00 | 376.00 | 574.00 | 444.00 | 876.00 | 858.00 | 1,047.00 |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -25.00 |
| Profit before tax | 445.00 | 376.00 | 574.00 | 444.00 | 876.00 | 858.00 | 1,022.00 |
| Current tax | 140.00 | 101.00 | 154.00 | 157.00 | 226.00 | 203.00 | 224.00 |
| Deferred tax | -14.00 | 3.00 | -2.00 | -40.00 | -15.00 | 5.00 | 23.00 |
| Tax expense | 127.00 | 104.00 | 152.00 | 116.00 | 211.00 | 208.00 | 247.00 |
| Profit for the period | 319.00 | 272.00 | 422.00 | 328.00 | 665.00 | 650.00 | 775.00 |
| Profit attributable to owners | 314.00 | 263.00 | 416.00 | 328.00 | 665.00 | 650.00 | 775.00 |
| Profit attributable to non-controlling interests | 5.00 | 8.00 | 5.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other comprehensive income | 4.00 | 2.00 | 6.00 | 60.00 | 22.00 | 30.00 | 140.00 |
| Total comprehensive income | 322.00 | 273.00 | 427.00 | 388.00 | 687.00 | 680.00 | 915.00 |
| Earnings per share, basic | 13.93 | 11.69 | 18.43 | 14.47 | 29.36 | 28.65 | 34.12 |
| Earnings per share, diluted | 13.70 | 11.53 | 18.27 | 14.40 | 29.13 | 28.43 | 33.69 |
Balance sheet, as filed
| Line | 2022-09-30 | 2023-03-31 | 2023-09-30 | 2024-03-31 | 2024-09-30 | 2025-03-31 | 2025-09-30 | 2026-03-31 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 3,899.00 | 4,121.00 | 4,401.00 | 4,648.00 | 4,822.00 | 5,173.00 | 5,412.00 | 6,084.00 |
| Non-current assets | 1,370.00 | 1,803.00 | 1,762.00 | 2,054.00 | 2,043.00 | 1,858.00 | 1,966.00 | 2,033.00 |
| Current assets | 2,529.00 | 2,318.00 | 2,640.00 | 2,594.00 | 2,779.00 | 3,315.00 | 3,446.00 | 4,050.00 |
| Property, plant and equipment | 357.00 | 326.00 | 283.00 | 224.00 | 191.00 | 188.00 | 178.00 | 105.00 |
| Capital work-in-progress | 1.00 | 0.00 | 0.00 | 5.00 | 6.00 | 1.00 | 6.00 | 1.00 |
| Goodwill | 732.00 | 745.00 | 751.00 | 756.00 | 902.00 | 914.00 | 949.00 | 1,004.00 |
| Other intangible assets | 148.00 | 102.00 | 72.00 | 54.00 | 76.00 | 68.00 | 57.00 | 47.00 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Trade receivables | 720.00 | 730.00 | 720.00 | 732.00 | 708.00 | 790.00 | 798.00 | 924.00 |
| Cash and cash equivalents | 470.00 | 474.00 | 481.00 | 443.00 | 346.00 | 271.00 | 374.00 | 416.00 |
| Total equity and liabilities | 3,899.00 | 4,121.00 | 4,401.00 | 4,648.00 | 4,822.00 | 5,173.00 | 5,412.00 | 6,084.00 |
| Equity | 2,764.00 | 2,976.00 | 3,252.00 | 3,562.00 | 3,706.00 | 4,070.00 | 4,279.00 | 4,719.00 |
| Equity share capital | 45.00 | 45.00 | 45.00 | 45.00 | 45.00 | 45.00 | 46.00 | 45.00 |
| Other equity | 2,719.00 | 2,931.00 | 3,207.00 | 3,517.00 | 3,660.00 | 4,024.00 | 4,234.00 | 4,674.00 |
| Total liabilities | 1,135.00 | 1,145.00 | 1,149.00 | 1,086.00 | 1,116.00 | 1,103.00 | 1,133.00 | 1,364.00 |
| Non-current liabilities | 302.00 | 287.00 | 256.00 | 232.00 | 273.00 | 221.00 | 205.00 | 214.00 |
| Current liabilities | 833.00 | 858.00 | 894.00 | 854.00 | 844.00 | 882.00 | 929.00 | 1,150.00 |
| Borrowings, non-current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Borrowings, current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Trade payables | 304.00 | 277.00 | 312.00 | 310.00 | 326.00 | 344.00 | 360.00 | 367.00 |
Cash flow, as filed
| Line | 2022-09-30 | 2023-03-31 | 2023-09-30 | 2024-03-31 | 2024-09-30 | 2025-03-31 | 2025-09-30 | 2026-03-31 |
|---|---|---|---|---|---|---|---|---|
| Net cash from operating activities | 304.00 | 714.00 | 316.00 | 642.00 | 172.00 | 565.00 | 307.00 | 771.00 |
| Net cash from investing activities | -217.00 | -528.00 | -188.00 | -475.00 | -96.00 | -480.00 | 64.00 | -241.00 |
| Net cash from financing activities | -124.00 | -219.00 | -121.00 | -197.00 | -190.00 | -264.00 | -275.00 | -401.00 |
| Purchase of property, plant and equipment | 42.00 | 37.00 | 6.00 | 16.00 | 16.00 | 37.00 | 23.00 | 54.00 |
| Net increase in cash | -36.00 | -31.00 | 7.00 | -31.00 | -105.00 | -172.00 | 103.00 | 146.00 |
| con:CFO.BEFORE_TAX | 314.00 | 807.00 | 409.00 | 875.00 | 275.00 | 786.00 | 400.00 | 965.00 |
| con:INTEREST_RECEIVED.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:INTEREST_PAID.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:DIVIDENDS_RECEIVED.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:TAX_PAID.OPERATING | 11.00 | 92.00 | 93.00 | 233.00 | 102.00 | 221.00 | 93.00 | 194.00 |
| con:CF_OTHER.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:INVESTMENTS_PURCHASED | 1,053.00 | 2,425.00 | 953.00 | 2,004.00 | 2,178.00 | 3,981.00 | 2,767.00 | 5,793.00 |
| con:INVESTMENTS_SOLD | 828.00 | 1,872.00 | 853.00 | 1,526.00 | 2,063.00 | 3,722.00 | 2,922.00 | 5,658.00 |
| con:PPE_DISPOSALS | 3.00 | 3.00 | 0.00 | 1.00 | 1.00 | 2.00 | 1.00 | 2.00 |
| con:CF_INVESTING.SUBSIDIARIES_SOLD | 1.00 | 3.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.SUBSIDIARIES_ACQUIRED | 0.00 | 0.00 | 0.00 | 0.00 | 120.00 | 120.00 | 1.00 | 1.00 |
| con:CF_INVESTING.JV_SOLD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.JV_ACQUIRED | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Who owns it
The shareholding pattern filed with the exchange every quarter, as a series. Percentages are of total shares. Each figure names the filing it was read from and the date it was filed.
| Holder | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoter and promoter group | 49.15 | 49.21 | 49.21 | 49.20 | 49.20 | 49.17 | 49.17 | 49.13 | 49.10 | 49.07 | 49.06 | 0.49 | 0.49 | 0.49 |
| Domestic institutions | 11.47 | 15.78 | 17.31 | 16.54 | 16.45 | 17.53 | 19.05 | 19.05 | 19.83 | 19.89 | 20.52 | 0.22 | 0.24 | 0.22 |
| Mutual funds | — | — | — | — | — | — | — | — | — | — | 17.88 | 0.20 | 0.21 | 0.20 |
| Insurance companies | 0.00 | 0.11 | 0.11 | 1.05 | 1.89 | 1.69 | 1.61 | 1.66 | 1.89 | 1.35 | 1.40 | 0.01 | 0.01 | 0.01 |
| Foreign institutions | 10.75 | 10.54 | 12.59 | 16.66 | 17.12 | 16.53 | 15.74 | 14.84 | 15.06 | 14.98 | 14.56 | 0.13 | 0.10 | 0.11 |
| Government | — | — | — | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | — |
| Public | 50.85 | 50.79 | 50.79 | 50.80 | 50.80 | 50.83 | 50.83 | 50.87 | 50.90 | 50.93 | 50.94 | 0.51 | 0.51 | 0.51 |
| Non-institutional | 28.63 | 24.47 | 20.90 | 17.60 | 17.23 | 16.76 | 16.05 | 16.97 | 16.01 | 16.06 | 15.86 | 0.15 | 0.16 | 0.18 |
| Shares outstanding | 226373644 | 226465358 | 226483891 | 226512982 | 226521592 | 226633191 | 226669140 | 226810436 | 226972224 | 227109412 | 227169322 | 227333181 | 227494454 | 227533892 |
Related parties
Transactions with related parties as disclosed to the exchange for the period ending 2024-09-30, by counterparty, largest first. Amounts are as filed. Each row names the filing and the date it was filed.
| Counterparty | Relationship | Type | Amount in the period | Transactions |
|---|---|---|---|---|
| Zensar Technologies INC. | SUBSIDIARY | Any other transaction, Sale of goods or services | 5,248,910,000.00 | 2 |
| Zensar Technologies (UK) Limited | SUBSIDIARY | Any other transaction, Dividend received, Sale of go | 3,185,320,000.00 | 3 |
| ZENSAR (SOUTH AFRICA) (PTY) LTD | SUBSIDIARY | Any other transaction, Sale of goods or services | 2,058,120,000.00 | 2 |
| Swallow Associates LLP | Entities which have the ability to | Dividend paid | 424,100,000.00 | 1 |
| M3BI India Pvt Ltd | SUBSIDIARY | Any other transaction, Dividend received, Purchase o | 272,320,000.00 | 4 |
| South Africa Holding | Subsidiary | Dividend received | 189,780,000.00 | 1 |
| Summit Securities Limited (Summit) | Entities which have the ability to | Dividend paid | 175,200,000.00 | 1 |
| Manish Tandon | Key Management Personnel | Any other transaction, Remuneration | 153,490,000.00 | 3 |
| Instant Holdings Limited | Entities which have the ability to | Dividend paid | 134,240,000.00 | 1 |
| RPG Enterprises Limited | Entities where Key management pers | Any other transaction, Purchase of goods or services | 97,750,000.00 | 2 |
| SOFREAL MERCANTRADE PVT LTD | Entities which have the ability to | Dividend paid | 42,020,000.00 | 1 |
| FoolProof Limited | SUBSIDIARY | Any other transaction, Sale of goods or services | 38,900,000.00 | 2 |
| Mr. Harsh Vardhan Goenka | Key Management Personnel | Any other transaction | 27,950,000.00 | 1 |
| RPG Foundation | Entities where Key management pers | Any other transaction | 22,770,000.00 | 2 |
| Mr. Anant Vardhan Goenka | Key Management Personnel | Any other transaction | 21,460,000.00 | 1 |
What management said
Every earnings call we hold for this company, read in full. Prepared remarks are separated from the question-and-answer session and every paragraph names who said it and on which page. These are management’s own words, not filed figures.
| Date | Quarter | Who spoke | |
|---|---|---|---|
| 2025-11-10 | Q2FY26 | LIMITED | Read the call |
| 2025-07-28 | Q1FY26 | LIMITED, ZENSAR TECHNOLOGIES LIMITED | Read the call |
| 2024-07-29 | Q1FY25 | Read the call | |
| 2024-05-02 | Q4FY24 | LIMITED | Read the call |
| 2024-01-30 | Q3FY24 | LIMITED | Read the call |
| 2023-07-26 | Q1FY24 | LIMITED | Read the call |
| 2023-05-17 | Q4FY23 | LIMITED | Read the call |
| 2023-01-31 | Q3FY23 | ZENSAR TECHNOLOGIES LIMITED | Read the call |
| 2019-01-29 | Q3FY19 | Limited, Zensar Technologies Limited | Read the call |
Some earlier announcements under this heading are covering letters only — no transcript was attached.
What they said about it, quarter by quarter
| Topic | Q1FY25 | Q1FY26 | Q2FY26 | Q3FY19 | Q3FY23 | Q3FY24 | Q4FY23 | Q4FY24 |
|---|---|---|---|---|---|---|---|---|
| Capex | — | I will take you through some of the key “Business and Financial Metrics” for the quarter ending June '25: Overall, macro environment remains challengi… | And what I would say is I see a more secular trend on TMT in terms of the amount of money that is being put in CapEx by some of our clients. | Great and one last question on the capex. | — | — | — | — |
| Capital allocation | So, Amit, financially, whatever we had to communicate on the acquisition, we have communicated in the filings. | So, I think when you look at the current cash balance, of course, there is a dividend, which is outstanding. | Because I think last year we did 2 large deals and anything on that front that could sort of help improve growth, anything from an acquisition perspec… | In terms of our acquisition, all acquired companies have had a strong quarter, and they all continue to play a pivotal role in their respective areas … | Be it improving the service line mix, be it improving the commercial with the customers, be it optimization of pyramid, support cost, and also improvi… | Sir, are you looking for any acquisition because we have got considerably cash and cash reserves and especially in Healthcare sector we are having les… | The Board of Directors has recommended a final dividend of INR3.5 per share for FY '23, subject to approval from shareholders. | And we are looking at acquisition targets also based on that. |
| Costs | — | And while the supply side seems to be like pretty good right now, attrition is low, is there a pocket on the supply side where there is a cost pressur… | — | — | — | — | — | I mean the more the sector is under stress, I would say, easier it is to pitch a large deal there, because they are looking at cost savings. |
| Demand | And also, from a large deal in the pipeline, how does that look? | We saw continued resilience in our key accounts and a healthy pipeline of AI-driven deals fueled by our ongoing investments in emerging technologies. | We launched ZenseAI, agentic AI platform to drive enterprise-level innovation and intelligence. • Zensar was named a challenger in Avasant Digital Mas… | Overall, pipeline remains very healthy and crossed $1 billion mark for the first time in our company. | As we called out in the last earnings call, the softness was due to the deceleration in the demand environment, where we have seen a segment of our cl… | We look at order booking and not order backlog. | The current demand environment continues to be challenging, driven by global uncertainty. | The first is, if you contrast where we are today from the total order bookings and, let's say, definitive client situations, how would you sort of con… |
| Guidance | So, I was just requesting to understand about your margin outlook for the year. | Looking ahead, while we anticipate some macro-driven variability in client budgets, our diversified portfolio and focus on high-value offerings positi… | We have also intensified the focus on enhancing the leadership proficiency in emerging AI areas, thereby creating a pool of strong strategic consultan… | I am not asking for a guidance on FY2020, but if you take this $500 million TCV which you have won, given that it is a long duration TCV, should we as… | However, insurance vertical saw a decline due to delay in decision making at some of our customers and right shifting of milestones that impacted us a… | — | But yes, the answer to latter part of your question is that, yes, if we are taking additional service offerings to the market, then if our existing cl… | But at the same time, we expect that the normalized depreciation going forward could continue to be in the range of $3.2 million to $3.5 million per q… |
| Margin | I know you have not asked about the margin, but I'm sure that the next question is going to be on the margin. | July 22, 2025 believe the margin walk could be slightly tougher in the next 2 quarters and still, we believe we could be closer to 15% for the full ye… | This quarter, Zensar delivered steady revenue and margin growth through disciplined execution and a sharp focus on capability building. | Overall, Q3 fiscal 2019, GM and EBITDA, were adversely affected. | Our gross margin stood at 27.4% in Q3 FY '23, representing a sequential Q-o-Q increase of 200 basis points while our EBITDA stood at 11.3%, a sequenti… | And Sachin if I presume you said in the opening remarks provision for doubtful debts has been reversed in this quarter which impacted margin by 110 ba… | Zensar Technologies Limited May 12, 2023 We exited Q4 FY '23 at an EBITDA of 14.5%, an increase of 320 basis points from previous quarters. | Congrats on a good execution, both on revenue and margin. |
| People | And in terms of the hiring plans, how do you see that in -- like we are running at 84% kind of utilization and what are the hiring plans? | Our LTM attrition further improved to 9.8% from 9.9% in the last quarter. | This coupled with 9.8% attrition demonstrates our commitment to employee recognition and financial discipline, while continuing to execute our strateg… | Our attrition rate stood at 16.6%, down 40 basis points from last quarter. | I'm pleased to share that for the third quarter, our last 12 months attrition declined to 22.8%, a sequential improvement of 350 basis points. | So, Sandeep combination of furloughs and utilization has impact of close to 200 basis points on our gross margins and normally the data of the split w… | LTM attrition for Q4 stood at 19.8%, which is lowest among the recent quarters has helped us manage the cost better. | Manish, over the course of last 12 to 15 months since you joined, we have still seen some amount of leadership flux in the organization, including som… |
| Pricing | — | And sir, just a related question, one of your large peers have said large deals are coming more on cost takeout and vendor consolidation and there is … | — | So is it the case that the deals that we are winning, mostly on the CIS side, are at the cost of margins or at a lower pricing because if you see the … | Look, my belief is that the pricing is determined by the market and margins is determined by execution. | — | — | — |
| Revenue growth | And how should we be thinking about our earlier thought process about seeing sequential revenue growth every single quarter through FY '25 in the back… | Our gross profit stood at 30.5%, sequential growth of 20 bps Q-on-Q and order book remains healthy. | For Q2 FY '26, Zensar reported revenues of $162.8 million, a year-over-year growth of 4.2% in reported currency, and 3.4% in constant currency. | In terms of topline, we had a very good Q3 fiscal 2019. | Banking, Financial Services and Insurance reported sequential Q-o-Q decline of 1.3%, but a Y-o-Y growth of 19.8% in constant currency. | So, I'm pretty bullish about our growth prospects, revenue growth prospects as far as non-Hi- Tech vertical is concerned. | For the financial year '23, the reported revenue in U.S. dollar terms stood at $604.2 million, reflecting growth of 6.1% year-on-year. | And it continues to be our aspiration, it continues to be our drive to make sure that we continue to have revenue growth every quarter. |